Loading Super Carl
Super Carl logo Super Carl Get Started
Insamo logo

Insamo

Biotechnology Research • Berkeley, California, United States

Insamo is a global biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic peptides with antibody-like binding affinity.

Website ↗ LinkedIn ↗ Crunchbase ↗

Reported headcount

17

Headcount reported in the resolved company record. It is independent of the number of profiles indexed by Super Carl.

Company record. Source date unavailable.

Observed active job postings

0

Active postings in the available job data. Postings may be duplicated or stale and are not a verified count of vacancies or hires.

Indexed job postings. Source date unavailable.

Reported total funding

2M

Reported cumulative funding in the available company record; missing value does not mean no funding.

Company record. Source date unavailable.

Reported latest funding round

2M

Reported amount of the latest funding round available in the company record.

Company record. Source date unavailable.

Calculated as of 2026-09-21. Source records may be older.

Company details

Industry

Biotechnology Research

Categories

Biotechnology, Membrane-Permeable, Antibody-Like Binding Affinity, Cyclic-Peptides, Drug Design, Health, Biotech, Drug-Development

Headquarters

Berkeley, California, United States

People associated with Insamo

Benjamin Kim profile photo

Benjamin Kim

Board Observer Lead Series Seed Investor at Insamo

See all associated people in Super Carl

Explore documented career histories and relationship context for people associated with this company.

Get started

Recent jobs

  • No active jobs in public preview yet.

Unlock full company intelligence in Super Carl

Explore hiring signals, people and company context, and AI-assisted outreach workflows.

Get started
Logging out…Taking longer than expected. Reload page
Skip to main content
↻